¿´Æ¬ÊÓÆµ

Object moved to here.

¿´Æ¬ÊÓÆµ :: Pilot & Feasibility Program Application

¿´Æ¬ÊÓÆµ


S-nitrosylation of extracellular matrix proteins in diabetic nephropathy
Summary Data Summary
Applicant Tufro, Alda
E-Mail Address alda.tufro@yale.edu
Project Title S-nitrosylation of extracellular matrix proteins in diabetic nephropathy
CBU ID 14GHSU1426
External SubContract ID 25732-50
Diabetic Complication Nephropathy
Funding Program Group Pilot & Feasibility [PF2014]
Abstract Diabetic nephropathy (ON) is the leading cause of end-stage renal disease
worldwide. The factors that induce ON in -30% of diabetic patients and the
molecular mechanisms leading to ON glomerular damage and renal failure are not
fully understood.
Protein S-nitrosylation is a redox-dependent, reversible post-translational
modification that plays important roles in physiology, insulin resistance and
cardiovascular disease. However, the role of protein S-nitrosylation in ON is
largely unknown. We recently identified laminin S-nitrosylation in glomeruli and
podocytes, and its regulation by nitric oxide (NO) and vascular endothelial
growth factor A (VEGF-A). We find that laminin de-nitrosylation associates with
laminin accumulation in glomerular nodules, suggesting a role in prototypical ON
lesions. Excessive TGF131 and CTGF signaling are responsible for mesangial. cell
proliferation and extracellular matrix expansion in human and rodent ON. We have
identified potential nitrosylation sites in active TGF131 and CTGF. We propose
to examine S-nitrosylation of the mature GBM laminin 521. TGFB1 and CTGF, which
are key contributors to extracellular matrix accumulation and nodular
glomerulosclerosis in ON. Aim 1 will evaluate laminin 521 S-nitrosylation: We
will assess S-nitrosylation of each (a5, 132 and yl ) laminin chain by
biotin-switch test (BST) and proximity link assay (PLA), identify nitrosylated
Cys residues by mutagenesis, BST and LC/MS/MS, and evaluate a5, 132 and y1
laminin-SNO effect on laminin secretion and degradation by podocytes, and on
glomerular nodule formation in advanced ON mouse models. Aim 2 will examine
TFGpl and CTGF S-nitrosylation. will determine whether endogenous TGFP1 and CTGF
are S-nitrosylated in mesangial cells and mouse kidneys using BSTI' and PLA, and
assess S-nitrosylation influence on TGFP1 and CTGF activity, measured by
mesangial cell proliferation, SMAO phosphorylation and collagen IV production. ,
Application PDF Application Research Plan
Status Contract Executed
Key Personnel
Salary Total Costs 45060
Supply Total Costs 15000
Equipment Total Costs 0
Travel/Other Total Costs 0
Direct Costs 60060
Indirect Costs Proposed 39940
Total Costs Proposed 100000
Total Costs Approved 100000
Start Date 10/1/2014
End Date 9/30/2015
IFO Name Clarke, Kenechia
IFO E-Mail Address kenechia.clarke@yale.edu
IACUC/IRB No. 999999
IACUC/IRB Institution Yale University
Entity ID No. 060646973
Report Request Date 10/30/2015
T1D NO
TypeCount
Invoices 9
Progress Reports 1
Data Submission


Invoices
UrlCBU IDExternal IDInstitutionDateDirectIndirectInvoiceBalancePDF
  View  14GHSU142625732-50Yale University9/4/2015$15,401.10-$15,401.10$1,027.73View PDF
  View  14GHSU142625732-50Yale University8/7/2015$7,635.13-$7,635.13$1,027.73View PDF
  View  14GHSU142625732-50Yale University7/21/2015$7,002.99-$7,002.99$1,027.73View PDF
  View  14GHSU142625732-50Yale University6/5/2015$7,003.09-$7,003.09$1,027.73View PDF
  View  14GHSU142625732-50Yale University5/7/2015$7,002.99-$7,002.99$1,027.73View PDF
  View  14GHSU142625732-50Yale University4/7/2015$7,002.99-$7,002.99$1,027.73View PDF
  View  14GHSU142625732-50Yale University3/9/2015$7,415.25-$7,415.25$1,027.73View PDF
  View  14GHSU142625732-50Yale University2/6/2015$7,415.21-$7,415.21$1,027.73View PDF
  View  14GHSU142625732-50Yale University11/16/2015$33,093.52-$33,093.52$1,027.73View PDF


Reports
Click here to cancel and return to funding program application

*Author:
*SubContract:
*Select File:

Click browse and select the file to upload.
(Please upload ONLY TXT, Image Files (not histolgy), PDF, XLS, XLSX, DOC, or DOCX files.)